Valeant Pharmaceuticals International (VRX) stock prices updated...
 

Valeant Pharmaceuticals International stock price

Valeant Pharmaceuticals International latest news:


  • 01/25/2018 13:04:55

    BRIEF-Valeant To Reduce Debt By An Additional $200 Million

    Valeant Pharmaceuticals International Inc(VRX) : * VALEANT - ‍PUT IN NOTICE TO PAY DOWN AN ADDITIONAL $200 MILLION OF ITS SENIOR SECURED TERM LOANS, USING CASH ON HAND​. * VALEANT - WHEN DEBT IS REPAID NEXT WEEK, CO TO HAVE REDUCED DEBT, IN AGGREGATE, BY MORE THAN $6.7 BILLION SINCE END OF Q1 OF 2016.

  • 01/24/2018 09:01:46

    CANADA STOCKS-TSX slips as Valeant, CN Rail weigh; gold stocks rally

    TORONTO, Jan 24 (Reuters) - Canada's main stock index edged lower on Wednesday, weighed by declines for Valeant Pharmaceuticals International Inc and Canadian National Railway Co, while gold mining stocks were boosted by higher gold prices.

  • 01/02/2018 22:33:49

    Pershing Square, Valeant to appear in court on insider trading suit settlement

    (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

  • 01/02/2018 22:33:10

    UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement

    Jan 2 (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

  • 01/02/2018 21:24:07

    Pershing Square, Valeant asked to appear for hearing on insider trading suit

    (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

  • 12/29/2017 12:16:55

    Pershing Square, Valeant arrive at settlement split for Allergan lawsuit

    (Reuters) - Activist investor William Ackman's Pershing Square and Valeant Pharmaceuticals on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc in 2014.

  • 12/29/2017 11:13:28

    Pershing Square and Valeant reach agreement on settlement split

    Activist investor William Ackman's Pershing Square said on Friday it had reached an agreement with Valeant Pharmaceuticals (VRX) to split settlement costs of a lawsuit related to Allergan Plc (AGN). Pershing Square said Valeant will now pay around 33 percent, or $96.25 million, of the settlement costs.

  • 12/29/2017 11:07:19

    Valeant says parties in Allergan litigation have agreed to resolve claims of $290 million

    Valeant Pharmaceuticals International Inc. said Friday that all parties in the Allergan Inc. shareholder securities litigation have agreed to resolve the claims that total $290 million, subject to court approval. The Quebec-based drug company said it will pay $96.25 million, or 33%, of the settlement. "Additionally, as part of the agreement, the company and the other defendants admit no wrongdoing," the company said. The other defendants include Pershing Square Capital Management L.P., the hedge fund run by activist shareholder Bill Ackman. "Though we always have remained confident in our position and were prepared to try these cases on their merits, this agreement will eliminate disruption to our business," Valeant Chief Executive Joseph Papa said in a statement. The litigation stems from an attempt by Valeant and Pershing to acquire Allergan in 2014. Allergan was later acquired by Actavis Plc. Valeant shares were slightly lower Friday, but have gained 45% in 2017, while the S&P 500 has gained about 20%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/21/2017 12:16:16

    Ex-Valeant CEO must arbitrate case over unpaid stock: U.S. judge

    Dec 21 (Reuters) - A U.S. judge has ruled that former Valeant Pharmaceuticals International Inc Chief Executive Officer Michael Pearson must pursue his claim that the drugmaker owes him more than 3 million shares with an arbitrator rather than in court.

  • 12/20/2017 14:19:46

    BRIEF-Valeant Completes Sale Of Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout

    Valeant Pharmaceuticals International Inc(VRX) : * VALEANT COMPLETES SALE OF SPROUT PHARMACEUTICALS SUBSIDIARY TO FORMER SHAREHOLDERS OF SPROUT PHARMACEUTICALS. * VALEANT - BEEN RELEASED FROM ONGOING OBLIGATIONS OF ORIGINAL DEAL TO SPLIT FUTURE PROFITS RELATED TO SALE OF ADDYI WITH FORMER SHAREHOLDERS OF SPROUT.

  • 12/18/2017 11:35:20

    Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal


  • 12/04/2017 16:08:13

    BRIEF-Valeant Announces Pricing Of Private Offering Of Senior Notes

    Dec 4 (Reuters) - Valeant Pharmaceuticals International Inc :

  • 12/04/2017 05:31:10

    Valeant is again borrowing in the bond market to repay debt

    Valeant Pharmaceuticals International Inc. said Monday it is once again borrowing in the bond market to repay debt. The Laval, Quebec-based company said it is planning to offer $1 billion of senior notes due 2025. Proceeds will used to repurchase $1 billion of its outstanding 5.3755 notes due 2020, as well as 7.000% notes due 2020 and 6.3755 notes due 2020. The company is further planning to repay 4175 million of sums outstanding under its revolving credit facility this week, using cash on hand. Valeant, which is still trying to rebound from a series of accounting and drug pricing scandals from 2015, has said it expects to beat its target of reducing debt by $5 billion by 2018. The company still hasabout $27 billion of long-term debt, according to FactSet. Shares were up 2% premarket, and have gained 19% in 2017, while the S&P 500 has gained 18%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Valero Energy CorporationVLO | Valero Energy Partners LPVLP | ValhiVHI | Validus HoldingsVR | Valley National BancorpVLY | Valley National BancorpVLY.WS | Valley National BancorpVLY^A | Valmont IndustriesVMI | Valspar Corporation (The)VAL | VantivVNTV |